China Insulin Delivery Market by Segment, region, Analysis and Forecast 2022
ReportsWeb.com published “China Insulin Delivery Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 09, 2017 ) Publisher's new report, "China Insulin Delivery Market Outlook to 2022", provides key market data on the China Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
For more information http://www.reportsweb.com/china-insulin-delivery-market-outlook-to-2022 .
Scope
- Market size and company share data for Insulin Delivery market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the China Insulin Delivery market.
- Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001530902/sample .
List of Tables
Table 1: Insulin Delivery Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Insulin Delivery Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Insulin Pens Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Insulin Pumps Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 13
Table 5: Insulin Pens Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 15
Table 6: Insulin Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Table 7: Insulin Delivery Market, China, Volume (Units), Historic, 2008-2015 18
Table 8: Insulin Delivery Market, China, Volume (Units), Forecast, 2015-2022 20
Table 9: Insulin Pens Market, China, Volume (Units), Historic, 2008-2015 22
Table 10: Insulin Pumps Market, China, Volume (Units), Historic, 2008-2015 23
Table 11: Insulin Pens Market, China, Volume (Units), Forecast, 2015-2022 25
Table 12: Insulin Pumps Market, China, Volume (Units), Forecast, 2015-2022 26
Table 13: Insulin Delivery Market, China, Average Price ($) Historic, 2008-2022 27
Table 14: Insulin Delivery Market, China, Average Price ($), Forecast, 2015-2022 28
Table 15: Insulin Delivery Market, China, Distribution Share by Revenue ($m), USD Constant, 2014-2015 29
Table 16: Insulin Delivery Market, China, Company Share by Revenue ($m), USD Constant, 2015 31
Table 17: Insulin Delivery Market Pipeline Products 35
Table 18: Harmony Biopharm Forms Joint Venture with Tonghua Dongbao Pharma and Shanghai Dongbao Biological Pharma 36
Table 19: Metabolon Enters into Licensing Agreement with Synlab 37
Companies Mentioned:
Medtronic plc
Eli Lilly and Company
Becton Dickinson and Co
F. Hoffmann-La Roche Ltd
Novo Nordisk A/S
Sanofi
Owen Mumford Ltd
B. Braun Melsungen AG
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001530902/buying .
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
For more information http://www.reportsweb.com/china-insulin-delivery-market-outlook-to-2022 .
Scope
- Market size and company share data for Insulin Delivery market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the China Insulin Delivery market.
- Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001530902/sample .
List of Tables
Table 1: Insulin Delivery Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Insulin Delivery Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Insulin Pens Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Insulin Pumps Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 13
Table 5: Insulin Pens Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 15
Table 6: Insulin Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Table 7: Insulin Delivery Market, China, Volume (Units), Historic, 2008-2015 18
Table 8: Insulin Delivery Market, China, Volume (Units), Forecast, 2015-2022 20
Table 9: Insulin Pens Market, China, Volume (Units), Historic, 2008-2015 22
Table 10: Insulin Pumps Market, China, Volume (Units), Historic, 2008-2015 23
Table 11: Insulin Pens Market, China, Volume (Units), Forecast, 2015-2022 25
Table 12: Insulin Pumps Market, China, Volume (Units), Forecast, 2015-2022 26
Table 13: Insulin Delivery Market, China, Average Price ($) Historic, 2008-2022 27
Table 14: Insulin Delivery Market, China, Average Price ($), Forecast, 2015-2022 28
Table 15: Insulin Delivery Market, China, Distribution Share by Revenue ($m), USD Constant, 2014-2015 29
Table 16: Insulin Delivery Market, China, Company Share by Revenue ($m), USD Constant, 2015 31
Table 17: Insulin Delivery Market Pipeline Products 35
Table 18: Harmony Biopharm Forms Joint Venture with Tonghua Dongbao Pharma and Shanghai Dongbao Biological Pharma 36
Table 19: Metabolon Enters into Licensing Agreement with Synlab 37
Companies Mentioned:
Medtronic plc
Eli Lilly and Company
Becton Dickinson and Co
F. Hoffmann-La Roche Ltd
Novo Nordisk A/S
Sanofi
Owen Mumford Ltd
B. Braun Melsungen AG
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001530902/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results